Grants and Contributions:
Agreement Number:
1008647
Agreement Value:
$563,000.00
Agreement Date:
Sep 4, 2023 - Oct 31, 2025
Description:
Development of a treatment for mucus hypersecretion associated with pulmonary diseases by delivery of antisense oligonucleotides using Feldan Shuttle technology
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4S6
Reference Number:
172-2023-2024-Q2-1008647
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
847961992
Recipient Type:
For-profit organization
Recipient's Operating Name:
Feldan Therapeutics
Recipient's Legal Name:
Feldan Bio inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410